首页> 外文期刊>Nucleic acids research >Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells
【24h】

Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells

机译:细胞骨架重组和TPA对AP-1的修饰不同,以诱导LLC-PK1细胞中的尿激酶型纤溶酶原激活基因

获取原文
           

摘要

Urokinase-type plasminogen activator (uPA) is an extracellular protease and expressed in various cells that exhibit dynamic changes in cell morphology, suggesting a link between cytoskeletal reorganization (CSR) and uPA expression. CSR can be induced by pharmacological agents, such as by colchicine for microtubule cytoskeleton and by cytochalasin for microfilament cytoskeleton. Using these agents, we previously showed that CSR induced the uPA gene in LLC-PK1 cells independently of the protein kinase C and cAMP-dependent protein kinase. Here we show that the induction of the uPA gene by CSR is mediated by the activation of c-Jun which interacts with an AP-1-like site located 2kb upstream of the uPA gene. 12-O-tetradecanoylphorbol 13-acetate (TPA) induces the uPA gene through the same elements, but additionally utilizes an adjacent PEA3 element and induces c-fos. Furthermore, CSR induces a greater accumulation and a more pronounced phosphorylation of c-Jun than TPA induction. AP-1 is a positive regulator of growth and oncogenesis, and CSR is an integral part of these processes. Our results provide a view how CSR and AP-1 could be coupled in these processes. We also show that TPA and CSR act synergistically, suggesting a model where an initial activation sIgnai could be amplified by CSR.
机译:尿激酶型纤溶酶原激活剂(uPA)是一种细胞外蛋白酶,在各种细胞中表达,这些细胞表现出细胞形态的动态变化,表明细胞骨架重组(CSR)和uPA表达之间存在联系。可以通过药理学试剂诱导CSR,例如秋水仙碱用于微管细胞骨架,细胞松弛素用于微丝细胞骨架。使用这些试剂,我们以前表明CSR在LLC-PK 1 细胞中诱导了uPA基因,而与蛋白激酶C和cAMP依赖性蛋白激酶无关。在这里,我们显示CSR对uPA基因的诱导是由c-Jun的激活介导的,该c-Jun与位于uPA基因上游2kb的AP-1样位点相互作用。 12-O-十四烷酰佛波醇13-乙酸盐(TPA)通过相同的元件诱导uPA基因,但另外利用相邻的PEA3元件并诱导c-fos。此外,与TPA诱导相比,CSR诱导c-Jun诱导更大的积累和更明显的磷酸化。 AP-1是生长和肿瘤发生的正向调节剂,而CSR是这些过程的组成部分。我们的结果为如何在这些过程中结合使用CSR和AP-1提供了一个观点。我们还表明,TPA和CSR协同作用,提示了一个模型,其中初始激活sIgnai可以被CSR放大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号